These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6075585)

  • 41. [Case of Cushing's syndrome with remarkable daily fluctuation of urinary 17-OHCS].
    Inagaki H; Nakashio K; Koizumi S; Kogure H
    Nihon Rinsho; 1967 Nov; 25(11):2617-20. PubMed ID: 5628393
    [No Abstract]   [Full Text] [Related]  

  • 42. The circadian periodicity of urinary 17-ketosteroids, corticosteroids, and electrolytes in congenital adrenal hyperplasia.
    Meyer WJ; Diller EC; Bartter FC; Halberg F
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1122-7. PubMed ID: 993315
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Influence of various neurotropic drugs (L-dopa and alphamethyl-dopa) in Cushing's disease].
    González-Bárcena D; Siller-Rodríguez J; Guzmán-Rangel Y; López-Luna M
    Arch Invest Med (Mex); 1974; 5(2):99-104. PubMed ID: 4547950
    [No Abstract]   [Full Text] [Related]  

  • 44. [Paradoxical response of adrenal glands to dexamethasone in a case of adrenal carcinoma].
    Medizinische Poliklinik der Universität Würzburg
    MMW Munch Med Wochenschr; 1975 May; 117(22):955-6. PubMed ID: 168485
    [No Abstract]   [Full Text] [Related]  

  • 45. [Present state of the dynamic studies of the adrenal cortex (excepting and aldosterone function)].
    Bricaire H; Leprat J; Luton JP
    Presse Med (1893); 1968 Nov; 76(45):2157-60. PubMed ID: 4305257
    [No Abstract]   [Full Text] [Related]  

  • 46. Lack of responsiveness to L-dopa in Cushing's disease.
    Krieger DT
    J Clin Endocrinol Metab; 1973 Feb; 36(2):277-84. PubMed ID: 4345691
    [No Abstract]   [Full Text] [Related]  

  • 47. [Chemical determination of adrenal cortex steroids and its significance for the medical diagnosis].
    Stahl F; Dörner G
    Z Gesamte Inn Med; 1968 Mar; 23(6):161-5. PubMed ID: 4882343
    [No Abstract]   [Full Text] [Related]  

  • 48. Remission of Cushing's syndrome after unilateral adrenal phlebography. Apparent destruction of adrenal adenoma.
    Fellerman H; Dalakos TG; Streeten DH
    Ann Intern Med; 1970 Oct; 73(4):585-9. PubMed ID: 4319080
    [No Abstract]   [Full Text] [Related]  

  • 49. A comparison of the 17-ketosteroid excretion in Cushing's syndrome associated with adrenal tumor and with adrenal hyperplasia.
    FORBES AP; ALBRIGHT F
    J Clin Endocrinol Metab; 1951 Sep; 11(9):926-35. PubMed ID: 14873765
    [No Abstract]   [Full Text] [Related]  

  • 50. Cushing's disease: megadose dexamethasone suppression in a case refractory to medical therapy.
    Warren SE; Westbie DK; Daly R; Bower RH
    South Med J; 1979 Apr; 72(4):412-4. PubMed ID: 219547
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test].
    Johannesen O; Jørgensen H; Frey H; Norman N
    Tidsskr Nor Laegeforen; 1989 Sep; 109(26):2678-82. PubMed ID: 2554527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Values for urinary free cortisol during treatment with amino-glutethimide for Cushing's syndrome.
    Schmitt KW; Juselius R; Hanlon J; Steed D
    Clin Chem; 1973 Sep; 19(9):1067-8. PubMed ID: 4744809
    [No Abstract]   [Full Text] [Related]  

  • 53. The effect of ACTH administration on aldosterone production in non salt-losing congenital adrenal hyperplasia.
    Beitins IZ; Bayard F; Kowarski A; Migeon CJ
    J Clin Endocrinol Metab; 1972 Oct; 35(4):595-603. PubMed ID: 4340790
    [No Abstract]   [Full Text] [Related]  

  • 54. [Studies on the alkaline granulocyte phosphatase (GAP) in endocrine diseases].
    Szatmári E; Lehoczky D; Fehér T
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 96(2):197-204. PubMed ID: 4111652
    [No Abstract]   [Full Text] [Related]  

  • 55. Cushing's syndrome with dual pituitary-adrenal control.
    Choi Y; Werk EE; Sholiton LJ
    Arch Intern Med; 1970 Jun; 125(6):1045-9. PubMed ID: 4378134
    [No Abstract]   [Full Text] [Related]  

  • 56. Urinary testosterone excretion in men in normal and pathological conditions.
    Ismail AA; Harkness RA
    Acta Endocrinol (Copenh); 1967 Nov; 56(3):469-80. PubMed ID: 6072466
    [No Abstract]   [Full Text] [Related]  

  • 57. Cortisol and its metabolites in the plasma and urine in Cushing's syndrome with chronic renal failure (CRF), compared to Cushing's syndrome without CRF.
    Otokida K; Fujiwara T; Oriso S; Kato M
    Nihon Jinzo Gakkai Shi; 1989 Jun; 31(6):651-6. PubMed ID: 2795994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Present knowledge on the treatment of Cushing's syndrome].
    Bricaire H; Albeaux-Fernet M; Lumbroso P; Netter A; Sebaoun J
    Presse Med (1893); 1969 Nov; 77(46):1665-8. PubMed ID: 5380390
    [No Abstract]   [Full Text] [Related]  

  • 59. The diagnosis of hypercortisolism. Biochemical criteria differentiating patients from lean and obese normal subjects and from females on oral contraceptives.
    Streeten DH; Stevenson CT; Dalakos TG; Nicholas JJ; Dennick LG; Fellerman H
    J Clin Endocrinol Metab; 1969 Sep; 29(9):1191-211. PubMed ID: 5808526
    [No Abstract]   [Full Text] [Related]  

  • 60. [Behavior of adrenal cortex hormones in obesity].
    Bunge HC; Ries W; Lieschke HJ
    Dtsch Z Verdau Stoffwechselkr; 1971; 31(3):135-44. PubMed ID: 4331911
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.